top of page
IMAGEN portraits-13 low res (2).jpg

Geoff Muckle

Board member, Chief Executive Officer (CEO)

Geoff Muckle is an accomplished pharmaceutical leader and oncology innovator with over 20 years of experience driving global business development, commercialising medical technologies, and advancing drug discovery programs. His expertise spans oncology therapeutics, diagnostics, CRO services, AI-driven precision medicine, and healthcare product development.

​

Geoff has played a pivotal role in the commercialisation of oncology-focused CRO services, contributing to hundreds of drug discovery and development programs worldwide during his tenure at Imagen Therapeutics and Champions Oncology. He has successfully scaled operations, secured international partnerships, and driven significant valuation growth, including building highly valuable proprietary data assets.

​

Geoff’s leadership extends across both established and start-up environments, including Roche, where he pioneered oncology portfolio strategies, and Link Medical Solutions, where he established a 42.49% CAGR over five years by spearheading AI-driven diagnostics and personalised medicine initiatives. Geoff is a passionate advocate for transforming oncology care and continues to push the boundaries of what is possible in pharmaceutical innovation and precision medicine.

​

Join our mailing list for updates on publications and events

Thanks for submitting!

Onconox Inc, 11 Deerpark Dr, Suite 128, Monmouth Junction, NJ 08852, USA

© 2023 by ONCONOX INC

bottom of page